Participant enrolment and retention key to clinical trial derisking
As the complexity of clinical trials continues to grow, enhancing patient centricity, improving site and contract research organisation (CRO) collaboration…
As the complexity of clinical trials continues to grow, enhancing patient centricity, improving site and contract research organisation (CRO) collaboration…
Artificial Intelligence (AI) is increasingly framed as a transformative tool that can address inefficiencies across therapeutic research and development (R&D).…
In April, Ipsen’s Ojemda (tovorafenib) secured European Commission (EC) approval for the treatment of relapsed or refractory paediatric low-grade glioma.…
Regulatory changes, geopolitical pressures and technological advancements are among the factors currently driving new and evolving challenges within the clinical…
The Netherlands is falling behind other European countries in providing access to advanced therapy medicinal products (ATMPs) according to Peter…
Clinical trials are facing new and evolving challenges as costs increase and approval timelines remain lengthy. Modernisation of processes and…
As the standard of care (SoC) for new drugs in oncology continues to improve, trials need to be designed with…
Pivotal regulatory reform, digitalisation and improved regional cooperation are transforming countries such as Argentina, Brazil, Mexico, and other Latin America…
Innovative approaches like synthetic control arms based on real-world data may help overcome the unique challenges faced in clinical trials…
As processes in drug development become increasingly digitalised, novel technologies that track progress of patient cohorts in real-time may allow…